HomeAPPH • ETR
add
Apontis Pharma AG
Previous close
€11.45
Day range
€11.20 - €11.55
Year range
€6.30 - €12.35
Market cap
98.22M EUR
Avg Volume
1.31K
P/E ratio
126.33
Dividend yield
-
Primary exchange
ETR
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 12.87M | 43.76% |
Operating expense | 6.81M | -13.48% |
Net income | 25.38K | 100.65% |
Net profit margin | 0.20 | 100.46% |
Earnings per share | — | — |
EBITDA | 648.52K | 134.52% |
Effective tax rate | 80.21% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.45M | -42.37% |
Total assets | 44.37M | -22.77% |
Total liabilities | 13.36M | -50.89% |
Total equity | 31.02M | — |
Shares outstanding | 8.33M | — |
Price to book | 3.08 | — |
Return on assets | 0.61% | — |
Return on capital | 0.87% | — |
Cash Flow
Net change in cash
| (EUR) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 25.38K | 100.65% |
Cash from operations | 488.13K | 126.98% |
Cash from investing | -835.19K | 10.67% |
Cash from financing | -3.67K | -100.12% |
Net change in cash | -350.73K | -237.00% |
Free cash flow | -248.14K | 87.58% |
About
Founded
1946
Website
Employees
137
